Cargando…

Vitamin D and breast cancer: interpreting current evidence

Preclinical investigations and selected clinical observational studies support an association between higher vitamin D intake and 25-hydroxyvitamin D levels with lower breast cancer risk. However, the recently updated report from the Institute of Medicine concluded that, for cancer and vitamin D, th...

Descripción completa

Detalles Bibliográficos
Autor principal: Chlebowski, Rowan T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236325/
https://www.ncbi.nlm.nih.gov/pubmed/21884640
http://dx.doi.org/10.1186/bcr2846
_version_ 1782218720334053376
author Chlebowski, Rowan T
author_facet Chlebowski, Rowan T
author_sort Chlebowski, Rowan T
collection PubMed
description Preclinical investigations and selected clinical observational studies support an association between higher vitamin D intake and 25-hydroxyvitamin D levels with lower breast cancer risk. However, the recently updated report from the Institute of Medicine concluded that, for cancer and vitamin D, the evidence was 'inconsistent and insufficient to inform nutritional requirements'. Against this background, reports examining vitamin D intake, 25-hydroxyvitamin D levels and breast cancer incidence and outcome were reviewed. Current evidence supports the pursuit of several research questions but not routine 25-hydroxyvitamin D monitoring and vitamin D supplementation to reduce breast cancer incidence or improve breast cancer outcome.
format Online
Article
Text
id pubmed-3236325
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32363252012-02-16 Vitamin D and breast cancer: interpreting current evidence Chlebowski, Rowan T Breast Cancer Res Review Preclinical investigations and selected clinical observational studies support an association between higher vitamin D intake and 25-hydroxyvitamin D levels with lower breast cancer risk. However, the recently updated report from the Institute of Medicine concluded that, for cancer and vitamin D, the evidence was 'inconsistent and insufficient to inform nutritional requirements'. Against this background, reports examining vitamin D intake, 25-hydroxyvitamin D levels and breast cancer incidence and outcome were reviewed. Current evidence supports the pursuit of several research questions but not routine 25-hydroxyvitamin D monitoring and vitamin D supplementation to reduce breast cancer incidence or improve breast cancer outcome. BioMed Central 2011 2011-08-16 /pmc/articles/PMC3236325/ /pubmed/21884640 http://dx.doi.org/10.1186/bcr2846 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Review
Chlebowski, Rowan T
Vitamin D and breast cancer: interpreting current evidence
title Vitamin D and breast cancer: interpreting current evidence
title_full Vitamin D and breast cancer: interpreting current evidence
title_fullStr Vitamin D and breast cancer: interpreting current evidence
title_full_unstemmed Vitamin D and breast cancer: interpreting current evidence
title_short Vitamin D and breast cancer: interpreting current evidence
title_sort vitamin d and breast cancer: interpreting current evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236325/
https://www.ncbi.nlm.nih.gov/pubmed/21884640
http://dx.doi.org/10.1186/bcr2846
work_keys_str_mv AT chlebowskirowant vitamindandbreastcancerinterpretingcurrentevidence